Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: B-Cell Lineage Envelope Design |
| Strategy: | Combo: Protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2013-10-07 |
| Study Made Public: | 2015-06-29 |
Title
Neutralization characteristics for sera from NHP Study 64 (bivalent vs. pentavalent gp120 boosts following 2X ALVAC priming)
Description
CAVD 430 is an immunogenicity study to evaluate the neutralization of specimens from NHP Study 64 that compared ALVAC/protein prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) GLA-SE (IDRI-EM005) gp120 pentavalent gp120 bivalentIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.